3Kamaraju AN, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor - beta -mediated Smad - dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem, 2005,280 (2): 1024- 1036.
4Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol,2001,159(4) : 1465 - 1475.
5Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol, 2002, 13 (10) : 2464 - 2477.
6Liu Y. Epithelial to mesenehymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutie intervention. J Am Soc Nephrol,2004,15( 1 ) : 1 - 12.
7Li Y, Yang J, Dai C, et al. Role for integrin - linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest, 2003, 112 (4) : 503 - 516.
9Wettschureck N, Offemlanns S. Rho/Rho kinase mediated signaling in physiology and pathophysiology. Mol Med, 2002,80(10) : 629 - 638.
10Uehata M, lshizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho - associated protein kinase in hypertension. Nature, 1997, 389 (6654) : 990 - 994.
2Allison E. Basic science review: molecular basis of renal fibrosis.Pediatric Nephrol, 2000, 15: 290-301.
3Nagatoya K, Moriyama T, Kawada N, et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int, 2002, 61: 1684-1695.
4Yasushi M, Hiroaki S, Tetsuya M, et al. Involvement of Rho kinase in hypertensive vascular disease: a novel therapeutic target in hypertention. FASEB,2001, 15: 1062-1064.
5Katafuchi R, Kiyoshi Y, OH Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation.Clin Nephrol, 1998, 49:1-8.
6Murata T, Arii S, Nakamura T, et al. Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. J Hepatol,2001,35:474-481.
7Wettschureck N and Offermanns S. Rho/ Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med, 2002,80: 629-638.
8Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-betal mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism . Mol Biol Cell, 2001, 12:27-36
9Mack CP, Somlyo AV, Hautmann M, et al. Smooth muscle differentiation marker gene expression is regulated by RhoAmediated actin polymerization. J Biol Chem, 2001,276: 341-347.
10De Larco JE, Todaro GJ. Growth factors from murine sarcoma virustransformed cells. Proc Natl Acad Sci USA, 1978, 75(8): 4001
2KUROKAWA K, ITOH R E, YOSHIZAKI H, et al. Coactivation of Racl and Cdc42 at lamellipodia and membrane ruffles induced by epi- dermal growth factor [J] . Mol Biol Cell, 2004, 15 (3) : 1003 - 1010.
3JI H, MENG Y, ZHANG X, et al. Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway [J] . Regul Pept, 2011, 169 (1 ：3): 13-20.
4VIATOUR P, MERVILLE MP, BOURS V, et al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflam- mation [J] . Trends Biochem Sci, 2005, 30 (1): 43-52.
5RODRIGUEZ PL, SAHAY S, OLABISI OO, et al. ROCK I -media- ted activation of NF-kappaB by RhoB [J] . Cell Signal, 2007, 19 (11) : 2361 -2369.
6HAMEL B, MONAGHAN-BENSON E, ROJAS R J, et al. SmgGDS isa guanine nucleotide exchange factor that specifically activates RhoA and RhoC [J] . J Biol Chem, 2011, 286 (14) : 12141 -12148.
7DIEZ-FREIRE C, VAZQUEZ J, CORREA DAM, et al. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR [J] . Physiol Genomics, 2006, 27 (1) : 12 -19.
8HUENTELMAN MJ, GROBE JL, VAZQUEZ J, et al. Protection from angiotensin H-induced cardiac hypertrophy and fibrosis by sys- temic lentiviral delivery of ACE2 in rats [ J ] . Exp Physiol, 2005, 90 (5): 783-790.
9VAN GOLEN KL, BAO L , DIVITO MM, et al. Reversion of RhoCGTPase-indueed ilu"lammatory breast cancer phenotype by treatment with a famesyl transferase inhibitor [J] . Mol Cancer Ther, 2002, 1 (8) : 575 -583.
10PAIZIS G, TIKELLIS C, COOPER ME, et O1. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2 [J] . Gut, 2005, 54 (12) : 1790 -1796.
